retatrutide phase 3 triumph Michael Weintraub, MD on X: "Looking forward to when #retatrutide's trial results will become available. There are are 4 planned trials investigating retatrutide's efficacy in treating obesity and its Starting Phase 3b Clinical Trial

Any potential synergy remains theoretical and unproven in human studies

A recent study found that more than half of patients with overweight or obesity (53.6%) discontinued GLP-1 therapy within one year (53.6%), a number that grows to 72.2% by two years

Hospira's manufacturing heritage ensures consistent, reliable formulation across all units

The researchers say riluzole itself is not ideal for use in autism because of its broad effects

Datwyler's halobutyl-based plungers, combiseals with DuraCoat laminate protection, and broad cartridge portfolio are positioned as key enabling components for pharmaceutical manufacturers scaling GLP-1 production globally